Results 101 to 110 of about 3,528,989 (183)

Gene manipulation to enhance MIBG-targeted radionuclide therapy

, 2005
The goal of targeted radionuclide therapy is the deposition in malignant cells of sterilizing doses of radiation without damaging normal tissue. The radiopharmaccutical [I-131] meta-iodobenzylguanidine ([I-131]MIBG) is an effective single agent for the ...
Fullerton, NE, Mairs, RJ, Cosimo, E, Boyd, M   +3 more
core   +1 more source

Targeted radionuclide therapy [PDF]

Journal of Labelled Compounds and Radiopharmaceuticals, 2007
openaire   +1 more source

Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes. [PDF]

Clin Cancer Res
Nonnekens J, Byers LA, Chauhan A, George DJ, Hicks RJ, Weber WA.   +5 more
europepmc   +1 more source

Cellular responses to targeted radionuclide therapy: rethinking radiobiology under continuous low dose rates. [PDF]

Front Oncol
Engbers PAM, Nonnekens J, Sabatella M.
europepmc   +1 more source

GATE Monte Carlo evaluation of cellular dosimetry for ¹¹⁹Sb in targeted radionuclide therapy. [PDF]

EJNMMI Phys
Hasnaki A, Chegeni N, Barati B, Divband G, Malekzadeh E.   +4 more
europepmc   +1 more source

Precision strikes: PSMA-targeted radionuclide therapy in prostate cancer - a narrative review. [PDF]

Front Oncol, 2023
Szponar P, Petrasz P, Brzeźniakiewicz-Janus K, Drewa T, Zorga P, Adamowicz J.   +5 more
europepmc   +1 more source

Context-dependent efficacy of fibroblast activation protein-targeted radionuclide therapy (FAP-TRT): the dual role of CAFs. [PDF]

Eur J Nucl Med Mol Imaging
Wu C, Kurniawan A, Li G, Ming Z, Nijkamp MW, van den Broek E, Noordzij W, Glaudemans AWJM, Antunes IF, Cornelissen B.   +9 more
europepmc   +1 more source

In Situ Vaccination, Low-Dose Targeted Radionuclide Therapy, and Immune Checkpoint Inhibition Eradicate Poorly Immunogenic Metastatic Tumors in Murine Cancer Models. [PDF]

Cancer Immunol Res
Debnath T, Jin WJ, Patel RB, Carlson PM, Rahman MM, Berg TJ, Kerr CP, Schwartz RW, Wang Y, Hyun M, Ong IM, Weichert JP, Hernandez R, Sondel PM, Morris ZS.   +14 more
europepmc   +1 more source

Targeted radionuclide therapy in endocrine-related cancers: advances in the last decade. [PDF]

Front Endocrinol (Lausanne), 2023
Al-Toubah T, Strosberg J, Hallanger-Johnson J, El-Haddad G.   +3 more
europepmc   +1 more source

Bridging the gaps in fibroblast activation protein targeted radionuclide therapy: a translational perspective. [PDF]

Eur J Nucl Med Mol Imaging
Wu C, Kurniawan A, Ming Z, Antunes IF, Noordzij W, Glaudemans A, Cornelissen B.   +6 more
europepmc   +1 more source